(Q35903683)

11 August 2017

1 reference

title

Malignant effusions: from diagnosis to biology (English)

1 reference

11 August 2017

Ben Davidson

1

1 reference

11 August 2017

publication date

1 October 2004

1 reference

11 August 2017

published in

Diagnostic Cytopathology

1 reference

11 August 2017

volume

31

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

246-254

1 reference

Flow Cytometric Analysis of Ploidy in Immunohistochemically Confirmed Examples of Malignant Epithelial Mesothelioma

11 August 2017

cites work

1 reference

Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination

21 January 2018

1 reference

Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients

21 January 2018

1 reference

Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects

21 January 2018

1 reference

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

21 January 2018

1 reference

Diagnostic problems in serous effusions

21 January 2018

1 reference

7 January 2021

Ovarian cancer stages I and II: predictions and 5-year survival in two decades

1 reference

7 January 2021

Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study

1 reference

7 January 2021

Pleural effusion in breast cancer: a review of 105 cases

1 reference

7 January 2021

Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma

1 reference

7 January 2021

Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis

1 reference

7 January 2021

Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.

1 reference

7 January 2021

Chromosome aberrations in nine patients with ovarian cancer

1 reference

7 January 2021

Cytogenetic study of cancer cells in effusions

1 reference

7 January 2021

Detection of chromosomal aberrations in tumor cells and tumor infiltrating lymphocytes by molecular cytogenetics in patients with gynecological cancer

1 reference

7 January 2021

Double minutes in prematurely condensed chromatin of human tumor cells

1 reference

7 January 2021

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

1 reference

7 January 2021

Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer

1 reference

7 January 2021

Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma

1 reference

7 January 2021

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

1 reference

7 January 2021

Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.

1 reference

7 January 2021

Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction.

1 reference

7 January 2021

Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion

1 reference

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

7 January 2021

Telomerase activity in human cancer.

1 reference

7 January 2021

Applications of the telomerase assay in peritoneal washing fluids

1 reference

7 January 2021

Telomerase activity in benign and malignant cytologic fluids

1 reference

7 January 2021

Telomerase activity in pleural effusions: diagnostic significance

1 reference

7 January 2021

Detection of telomerase expression in fine-needle aspirations and fluids

1 reference

7 January 2021

Telomerase activity in human gynaecological malignancies

1 reference

7 January 2021

Pitfalls in TRAP assay in routine detection of malignancy in effusions

1 reference

7 January 2021

The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology

1 reference

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

7 January 2021

Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer

1 reference

7 January 2021

Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer

1 reference

7 January 2021

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

1 reference

7 January 2021

AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients

1 reference

7 January 2021

Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro

1 reference

7 January 2021

alphavbeta3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation

1 reference

7 January 2021

Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin

1 reference

7 January 2021

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

1 reference

7 January 2021

Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma

1 reference

7 January 2021

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

1 reference

7 January 2021

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

1 reference

7 January 2021

Cadherin switching in ovarian cancer progression.

1 reference

7 January 2021

Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques

1 reference

7 January 2021

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

1 reference

7 January 2021

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions

1 reference

7 January 2021

Chemokines: key players in cancer

1 reference

7 January 2021

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

1 reference

7 January 2021

Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space

1 reference

7 January 2021

The Hallmarks of Cancer

1 reference

7 January 2021

Alterations in the apoptotic machinery and their potential role in anticancer drug resistance

1 reference

7 January 2021

Soluble Fas in malignant pleural effusion and its expression in lung cancer cells

1 reference

7 January 2021

Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis

1 reference

7 January 2021

Neurotrophic factors and their receptors

1 reference

7 January 2021

Signal transduction by the neurotrophin receptors

1 reference

7 January 2021

Trk receptors: mediators of neurotrophin action

1 reference

7 January 2021

Trk receptor tyrosine kinases: a bridge between cancer and neural development

1 reference

7 January 2021

Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma

1 reference

7 January 2021

The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

1 reference

7 January 2021

Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survival

1 reference

7 January 2021

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

1 reference

7 January 2021

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

1 reference

7 January 2021

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

1 reference

7 January 2021

Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications

1 reference

7 January 2021

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

1 reference

7 January 2021

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma

1 reference

7 January 2021

Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome

1 reference

7 January 2021

Mammalian MAP kinase signalling cascades

1 reference

7 January 2021

Organization and regulation of mitogen-activated protein kinase signaling pathways

1 reference

7 January 2021

Dual specificity phosphatases: a gene family for control of MAP kinase function.

1 reference

7 January 2021

Regulation of stress-activated protein kinase signaling pathways by protein phosphatases

1 reference

7 January 2021

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma

1 reference

7 January 2021

Clinical proteomics: translating benchside promise into bedside reality

1 reference

7 January 2021

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.20133

1 reference

11 August 2017

1 reference